Lung cancer is the world's leading cause of cancer-related deaths. Epidermal growth factor
receptor (EGFR) is one of the critical oncogenes and plays a significant role in tumor …

Epidermal growth factor receptor (EGFR) is one of the targeted molecular markers in many
cancers including the lung malignancy. Genetic modifications such as deletions, insertions …

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the
prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR …

Screening for EGFR mutation is a key molecular test for management of lung cancer
patients. Outcome of patients with mutation receiving EGFR tyrosine kinase inhibitor is …

BACKGROUND: Lung cancer is the leading cause of cancer related mortality world-wide
and amongst males in India. The discovery of tyrosine kinase inhibitors holds a ray of hope …

AIMS: To report the incidence of EGFR mutation and its correlation with the phenotypical
characteristics, in NSCLC patients from Kolkata. SUBJECTS AND METHODS: NSCLC …

The presence of activating mutations in the tyrosine kinase domain of the epidermal growth
factor receptor (EGFR) gene in adenocarcinomas of lung confers sensitivity to tyrosine …

Background: Epidermal growth factor receptor (EGFR) mutation analysis has become an
important part of the initial workup of non-squamous non-small cell lung cancer (NS …

Introduction Mutations in the tyrosine kinase domain of the epidermal growth factor receptor
gene (EGFR) are key driver alterations in lung adenocarcinomas (ADCAs). Exon 19 …

MATERIALS AND METHODS: All patients with confirmed non-small cell lung cancer
(NSCLC) during Jan 2008 to Dec 2010 were included. EGFR sequencing was performed …